Cargando…

Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases

Objective  Concentrated growth factor (CGF) is particularly gaining acceptance and popularity in regenerative dentistry. Nonetheless, there are no available studies showing its effect against microorganisms of oral cavity particularly in chronic oral disease-induced biofilms. This in vitro research...

Descripción completa

Detalles Bibliográficos
Autores principales: Alauddin, Muhammad Syafiq, Yusof, Nabilah Mohd, Adnan, Aini Sufinah, Said, Zulfahmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683896/
https://www.ncbi.nlm.nih.gov/pubmed/35189641
http://dx.doi.org/10.1055/s-0041-1742121
_version_ 1784835155193495552
author Alauddin, Muhammad Syafiq
Yusof, Nabilah Mohd
Adnan, Aini Sufinah
Said, Zulfahmi
author_facet Alauddin, Muhammad Syafiq
Yusof, Nabilah Mohd
Adnan, Aini Sufinah
Said, Zulfahmi
author_sort Alauddin, Muhammad Syafiq
collection PubMed
description Objective  Concentrated growth factor (CGF) is particularly gaining acceptance and popularity in regenerative dentistry. Nonetheless, there are no available studies showing its effect against microorganisms of oral cavity particularly in chronic oral disease-induced biofilms. This in vitro research was conducted to determine the antimicrobial effects of CGF against Staphylococcus aureus sp. ( S. aureus ) and Streptococcus mutans sp. ( S. mutans ). Materials and Methods  Blood samples were obtained from a healthy volunteer. CGF was then prepared using specialized centrifugation equipment (Medifuge, Silfradent, Santa Sofia FC, Italy) and protocol. Antimicrobial activity of the CGF was observed and recorded on standard strains of S. aureus and S. mutans using a well diffusion method to determine the inhibition zone, broth microdilution to determine minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and crystal violet assay for biofilm assessment, with chlorhexidine (CHX) 0.12% used as a positive control. Statistical analysis was then performed using one-way analysis of variance followed by Tukey Test post hoc analysis. Results  It was observed that there was a presence of clear zones of inhibition around the CGF after 24 hours of incubation. The mean diameter of the inhibition zone was 1.26 ± 0.12 nm and 1.20 ± 0.06 nm for S. aureus and S. mutans , respectively, with significance difference ( p  < 0.05) against the control group CHX 0.12%. The MIC values of the CGF against S. aureus and S. mutans were 47.9% and 34.17%, respectively, and the MBC values of the CGF against S. aureus and S. mutans were 100%. The viability and the ability in inhibiting the biofilm formation of S. mutans and S. aureus following treatment with CGF showed a reduction in the concentration-dependent manner as compared with the control group. Conclusion  CGF possesses antimicrobial and antibiofilm activity against S. aureus and S. mutans .
format Online
Article
Text
id pubmed-9683896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96838962022-11-24 Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases Alauddin, Muhammad Syafiq Yusof, Nabilah Mohd Adnan, Aini Sufinah Said, Zulfahmi Eur J Dent Objective  Concentrated growth factor (CGF) is particularly gaining acceptance and popularity in regenerative dentistry. Nonetheless, there are no available studies showing its effect against microorganisms of oral cavity particularly in chronic oral disease-induced biofilms. This in vitro research was conducted to determine the antimicrobial effects of CGF against Staphylococcus aureus sp. ( S. aureus ) and Streptococcus mutans sp. ( S. mutans ). Materials and Methods  Blood samples were obtained from a healthy volunteer. CGF was then prepared using specialized centrifugation equipment (Medifuge, Silfradent, Santa Sofia FC, Italy) and protocol. Antimicrobial activity of the CGF was observed and recorded on standard strains of S. aureus and S. mutans using a well diffusion method to determine the inhibition zone, broth microdilution to determine minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and crystal violet assay for biofilm assessment, with chlorhexidine (CHX) 0.12% used as a positive control. Statistical analysis was then performed using one-way analysis of variance followed by Tukey Test post hoc analysis. Results  It was observed that there was a presence of clear zones of inhibition around the CGF after 24 hours of incubation. The mean diameter of the inhibition zone was 1.26 ± 0.12 nm and 1.20 ± 0.06 nm for S. aureus and S. mutans , respectively, with significance difference ( p  < 0.05) against the control group CHX 0.12%. The MIC values of the CGF against S. aureus and S. mutans were 47.9% and 34.17%, respectively, and the MBC values of the CGF against S. aureus and S. mutans were 100%. The viability and the ability in inhibiting the biofilm formation of S. mutans and S. aureus following treatment with CGF showed a reduction in the concentration-dependent manner as compared with the control group. Conclusion  CGF possesses antimicrobial and antibiofilm activity against S. aureus and S. mutans . Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-02-21 /pmc/articles/PMC9683896/ /pubmed/35189641 http://dx.doi.org/10.1055/s-0041-1742121 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Alauddin, Muhammad Syafiq
Yusof, Nabilah Mohd
Adnan, Aini Sufinah
Said, Zulfahmi
Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases
title Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases
title_full Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases
title_fullStr Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases
title_full_unstemmed Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases
title_short Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases
title_sort preliminary novel analysis on antimicrobial properties of concentrated growth factor against bacteria-induced oral diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683896/
https://www.ncbi.nlm.nih.gov/pubmed/35189641
http://dx.doi.org/10.1055/s-0041-1742121
work_keys_str_mv AT alauddinmuhammadsyafiq preliminarynovelanalysisonantimicrobialpropertiesofconcentratedgrowthfactoragainstbacteriainducedoraldiseases
AT yusofnabilahmohd preliminarynovelanalysisonantimicrobialpropertiesofconcentratedgrowthfactoragainstbacteriainducedoraldiseases
AT adnanainisufinah preliminarynovelanalysisonantimicrobialpropertiesofconcentratedgrowthfactoragainstbacteriainducedoraldiseases
AT saidzulfahmi preliminarynovelanalysisonantimicrobialpropertiesofconcentratedgrowthfactoragainstbacteriainducedoraldiseases